Related Experiment Video
Updated: Aug 30, 2025

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
Effect of Calcium Channel Blockers versus Diuretics for Hypertension
Yi Chunxue1, Zhang Jianming1, Wang Jianbing1
1Chongqing University, Three Gorges Hospital, Chongqing, China.
Calcium channel blockers (CCBs) and diuretics show no significant difference in mortality or major cardiovascular events for hypertension patients. Further large trials are needed to fully validate these findings for clinical guidance.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Calcium channel blockers (CCBs) are a first-line treatment for hypertension.
- The combination of CCBs with diuretics for hypertensive cardiovascular disease is controversial.
Purpose of the Study:
- To evaluate the efficacy of CCBs compared to diuretics in managing hypertension.
- To assess the impact of CCBs versus diuretics on cardiovascular outcomes.
Main Methods:
- A systematic search of Cochrane Library, EMBASE, and PubMed databases was conducted.
- The search included randomized controlled trials and meta-analyses from January 1991 to October 2021.
- Keywords included "calcium channel blockers," "diuretics," and "hypertension."
Main Results:
- No statistically significant difference in all-cause mortality was found between CCBs and diuretics in 5 studies (35,057 patients).
- Major cardiovascular events did not differ significantly between CCBs and diuretics in 4 studies (33,643 patients).
- Statistical heterogeneity (I²=0) was minimal across the analyzed studies.
Conclusions:
- CCBs and diuretics demonstrate comparable cardiovascular clinical prognoses in hypertensive patients.
- The findings suggest potential clinical implications, warranting validation through new large-scale randomized controlled trials.
More Related Videos
07:51Mesenteric Artery Contraction and Relaxation Studies Using Automated Wire Myography
Published on: September 22, 2011
07:42Contractions of Human-iPSC-derived Cardiomyocyte Syncytia Measured with a Ca-sensitive Fluorescent Dye in Temperature-controlled 384-well Plates
Published on: October 18, 2018
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Antihypertensive Drugs: Action of Diuretics
Antihypertensive Drugs: Thiazide-Class Diuretics
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Antihypertensive Drugs: Potassium-Sparing Diuretics